πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,435 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10759768

Prophylactic or therapeutic agent for autism spectrum disorder

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10745397

1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10745475

Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as anal

TAKEDA GMBH Β· Granted Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10738004

Cyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10738046

Substituted pyrido[3,4-b]pyrazines as GPR6 modulators

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10717748

1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative di

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10710989

Method for producing heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10696651

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10688174

Method of conferring a protective immune response to norovirus

Takeda Vaccines, Inc. Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10689373

1,2-substituted cyclopentanes as orexin receptor antagonists

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10676461

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10676473

Solid state forms of fused heteroaromatic pyrrolidinones

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10675341

Parenteral norovirus vaccine formulations

Takeda Vaccines, Inc. Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10668260

Microneedle patch

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10654874

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10632184

Compositions and methods for stabilizing alphaviruses with improved formulations

Takeda Vaccines, Inc. Β· Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10610520

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10597392

Tetrahydropyridopyrazines as modulators of GPR6

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10584097

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10577382

Fused heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10570091

Method for producing pyrrole compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10561662

4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10562882

Piperidine derivatives for use in the treatment or prevention of psychiatric and neurologi

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10556256

Antibacterial water

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted